Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Canal

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
L' Orthodontie Francaise|October 12, 2016
[Growth and dental implants: assessment and prevention of the long-term aesthetic risk]Philippe Bousquet, Hélène Ansermino, Pierre Canal, et al.
Biochemical Pharmacology|September 18, 2002
Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell lineStéphanie Arnould, Sylvie Guichard, Isabelle Hennebelle, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisationJean-Pierre Delord, Frédéric Léger, Pierre Canal, et al.
International Orthodontics|April 14, 2018
Inès Dallel, Wiem Marwen, Sofiene Ben Abdallah, et al.
FEBS Letters|September 11, 2004
Atypical protein kinase C stimulates nucleotide excision repair activityThierry Louat, Yvan Canitrot, Sandra Jousseaume, et al.
International Orthodontics|April 14, 2018
Agenesis of the upper lateral incisors: Study of an orthodontic population and clinical illustrationInès Dallel, Wiem Marwen, Sofiene Ben Abdallah, et al.
International Orthodontics|July 25, 2025
Quality of occlusal outcome in adult patients with posterior crossbite treated with completely customized lingual appliances and CAD/CAM archwires for maxillary expansion and mandibular compression compared to adult Class I patients: A retrospective studyYann Janssens, Heike Siekmann, Pierre Canal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Serum cystatin C is a better marker of topotecan clearance than serum creatinineAntje Hoppe, Sophie Séronie-Vivien, Fabienne Thomas, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2003
Population pharmacokinetics of oxaliplatinJean-Pierre Delord, Amine Umlil, Rosine Guimbaud, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2005
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFRDiane Balin-Gauthier, Jean-Pierre Delord, Philippe Rochaix, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
L' Orthodontie Francaise|October 12, 2016
[Growth and dental implants: assessment and prevention of the long-term aesthetic risk]Philippe Bousquet, Hélène Ansermino, Pierre Canal, et al.
Biochemical Pharmacology|September 18, 2002
Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell lineStéphanie Arnould, Sylvie Guichard, Isabelle Hennebelle, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2005
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisationJean-Pierre Delord, Frédéric Léger, Pierre Canal, et al.
International Orthodontics|April 14, 2018
Inès Dallel, Wiem Marwen, Sofiene Ben Abdallah, et al.
FEBS Letters|September 11, 2004
Atypical protein kinase C stimulates nucleotide excision repair activityThierry Louat, Yvan Canitrot, Sandra Jousseaume, et al.
International Orthodontics|April 14, 2018
Agenesis of the upper lateral incisors: Study of an orthodontic population and clinical illustrationInès Dallel, Wiem Marwen, Sofiene Ben Abdallah, et al.
International Orthodontics|July 25, 2025
Quality of occlusal outcome in adult patients with posterior crossbite treated with completely customized lingual appliances and CAD/CAM archwires for maxillary expansion and mandibular compression compared to adult Class I patients: A retrospective studyYann Janssens, Heike Siekmann, Pierre Canal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Serum cystatin C is a better marker of topotecan clearance than serum creatinineAntje Hoppe, Sophie Séronie-Vivien, Fabienne Thomas, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2003
Population pharmacokinetics of oxaliplatinJean-Pierre Delord, Amine Umlil, Rosine Guimbaud, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2005
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFRDiane Balin-Gauthier, Jean-Pierre Delord, Philippe Rochaix, et al.
Pageof 3